Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$178,820
-$169,895 QoQ
Shares Held
1,061
-59.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#611
of 772 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NATIXIS holds $26,466,635 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
127,706 | $9,176,953 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
14,571 | $7,895,004 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
126,100 | $5,173,883 | |
| 4 | VTRS |
Viatris Inc
|
69,836 | $1,108,995 | |
| 5 | EOLS |
Evolus, Inc.
|
141,437 | $981,572 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
28,444 | $963,682 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
34,000 | $862,580 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,061 | $178,820 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $178,820 | 1,061 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $348,715 | 2,647 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $553,704 | 3,904 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $754,261 | 5,373 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $286,824 | 2,282 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $135,927 | 1,229 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $202,702 | 1,485 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $65,329 | 567 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $156,806 | 1,139 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $218,051 | 1,581 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $250,871 | 1,904 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $279,225 | 2,482 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,114,771 | 22,426 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,662,538 | 16,425 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,332,876 | 44,649 | Shares | Sole | 2023-02-24 | |
| 2022-06-30 | $206,852 | 2,122 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $304,781 | 3,251 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $323,134 | 3,794 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $402,246 | 4,194 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $722,503 | 7,424 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $386,275 | 4,030 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $455,304 | 3,732 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||